MedEdTalks - Ophthalmology

MedEdTalks - Ophthalmology

By Vindico Medical EducationScienceMedicineHealth & Fitness
Download on the App Store

All MedEdTalks - Ophthalmology episodes

  • A New Era in TED: Navigating Choice, Sequencing, and Long-Term Care

    The management of thyroid eye disease (TED) is entering a new era marked by the availability of multiple FDA-approved IGF-1R-targeted therapies and a growing pipeline of emerging treatment options. As the treatment landscape continues to evolve, clinicians require practical guidance to make informed, patient-centered therapeutic decisions across the disease continuum. Delivered in a dynamic Rapid-Fire Roundtable format, this activity will provide participants with expert insights into available therapies, highlighting key differences in clinical evidence, safety profiles, patient selection, retreatment strategies, and challenges to real-world implementation.

    To claim CE credit after listening to this episode, go to this link and check the "Already listened on another platform?" box:
    48 min
  • S4E1: The Retina Radar Season 4 With Dr. Arshad Khanani: Clinical Trials at the Summit 2026 With Drs. David Boyer and Anat Loewenstein

    In this podcast, expert faculty review the therapeutic landscape of vitreoretinal care and discuss the latest from Clinical Trials at the Summit 2026.

    To claim CE credit after listening to this episode, go to this link and check the "Already listened on another platform?" box: https://vindicocme.com/mededtalks/1the-retina-radar-season-4-with-dr-arshad-khanani-clinical-trials-at-the-summit-2026-with-drs-david-boyer-and-anat-loewenstein-blt810e98f995192db2/overview

    47 min
  • S4E2: The Retina Radar Season 4 With Dr. Arshad Khanani: Latest in nAMD Management in 2026 With Dr. Yasha Modi

    In this podcast, expert faculty discuss durability-focused treatment strategies and long-term clinical data to optimize outcomes for patients with nAMD.

    To claim CE credit after listening to this episode, go to this link and check the "Already listened on another platform?" box: https://vindicocme.com/mededtalks/2the-retina-radar-season-4-with-dr-arshad-khanani-latest-in-namd-management-in-2026-with-dr-yasha-modi-bltbc205cf637dc6313/overview

    49 min
  • S4E3: The Retina Radar Season 4 With Dr. Arshad Khanani: Latest in DME Management in 2026 With Dr. Margaret Chang

    In this podcast, expert faculty discuss the latest clinical trial data and real-world studies on approved and emerging therapies for DME.

    To claim CE credit after listening to this episode, go to this link and check the "Already listened on another platform?" box: https://vindicocme.com/mededtalks/3the-retina-radar-season-4-with-dr-arshad-khanani-latest-in-dme-management-in-2026-with-dr-margaret-chang-blt0238f9ad223ce3d2/overview

    44 min
  • S4E4: The Retina Radar Season 4 With Dr. Arshad Khanani: What's New for RVO in 2026? With Dr. Ehsan Rahimy

    In this podcast, expert faculty discuss current treatment strategies and emerging clinical data to optimize outcomes for patients with RVO.

    To claim CE credit after listening to this episode, go to this link and check the "Already listened on another platform?" box: https://vindicocme.com/mededtalks/4the-retina-radar-season-4-with-dr-arshad-khanani-what-s-new-for-rvo-in-2026-with-dr-ehsan-rahimy-blt18909863eb2c3acd/overview

    43 min
  • Updates from EURETINA, Retina Society, and AAO: nAMD, DME/DR, and RVO Treatment

    The treatment landscape for neovascular age-related macular degeneration (nAMD), diabetic macular edema (DME), diabetic retinopathy (DR), and retinal vein occlusion (RVO) continues to evolve, with ongoing efforts to improve durability and reduce treatment burden. Longer-acting second-generation anti-VEGF therapies, including aflibercept 8 mg and faricimab, have demonstrated the potential to extend dosing intervals while maintaining improved visual and anatomic outcomes across these retinal diseases. Emerging real-world and extension-study data are further informing the long-term safety, efficacy, and clinical application of these therapies. However, adherence barriers, undertreatment, safety considerations, access disparities, and uncertainty regarding patient selection continue to present challenges in achieving optimal outcomes. Clinicians must also understand differences in clinical trial design to critically interpret emerging evidence and apply durability data into individualized patient care. In this Rapid Response CE activity, experts in the field review abstracts presented at EURETINA, Retina Society, and The American Academy of Ophthalmology and discuss recent clinical evidence on approved second-generation anti-VEGF therapies to support evidence-based management of treatment naïve and previously treated patients with retinal diseases.

    To claim CME credit, please visit HealioCME.com and search for this activity title

    14 min
  • Current Evidence for Oral Micronutrient Therapy in AMD With Drs. Rishi Singh and Lejla Vajzovic

    This podcast series delves into the evidence for oral micronutrient therapy in slowing the progression of age-related macular degeneration (AMD). In this episode, experts in the field discuss the evidence base for AMD-specific supplementation and key considerations for incorporating oral micronutrient therapy into AMD management.

    To claim CE credit after listening to this episode, go to this link and check the "Already listened on another platform?" box: https://www.healio.com/cme/mededtalks/ophthalmology/20260828/1current-evidence-for-oral-micronutrient-therapy-in-amd

    15 min
  • Emerging Evidence on B Vitamins and Expanded Nutritional Strategies in AMD With Drs. Rishi Singh and Julie Poteet

    This podcast series delves into the evidence for oral micronutrient therapy in slowing the progression of age-related macular degeneration (AMD). In this episode, experts in the field discuss the emerging evidence for incorporation of B vitamins into AMD supplementation and implications for evolving oral micronutrient strategies.

    To claim CE credit after listening to this episode, go to this link and check the "Already listened on another platform?" box: https://www.healio.com/cme/mededtalks/ophthalmology/20260828/2emerging-evidence-on-b-vitamins-and-expanded-nutritional-strategies-in-amd

    13 min
  • What's Next for Nutritional Strategies in AMD Care With Drs. Rishi Singh and Jeffry Gerson

    This podcast series delves into the evidence for oral micronutrient therapy in slowing the progression of age-related macular degeneration (AMD). In this episode, experts in the field discuss potential implications of expanded formulations of AMD supplements and interprofessional approaches for counseling patients.

    To claim CE credit after listening to this episode, go to this link and check the "Already listened on another platform?" box: https://www.healio.com/cme/mededtalks/ophthalmology/20260828/3whats-next-for-nutritional-strategies-in-amd-care

    11 min
  • Updates from ASRS: nAMD, DME/DR, and RVO Treatment

    The treatment landscape for neovascular age-related macular degeneration (nAMD), diabetic macular edema (DME), diabetic retinopathy (DR), and retinal vein occlusion (RVO) continues to evolve, with ongoing efforts to improve durability and reduce treatment burden. Longer-acting second-generation anti-VEGF therapies, including aflibercept 8 mg and faricimab, have demonstrated the potential to extend dosing intervals while maintaining improved visual and anatomic outcomes across these retinal diseases. Emerging real-world and extension-study data are further informing the long-term safety, efficacy, and clinical application of these therapies. However, adherence barriers, undertreatment, safety considerations, access disparities, and uncertainty regarding patient selection continue to present challenges in achieving optimal outcomes. Clinicians must also understand differences in clinical trial design to critically interpret emerging evidence and apply durability data into individualized patient care. In this Rapid Response CE activity, experts in the field review abstracts presented at The American Society of Retina Specialists and discuss recent clinical evidence on approved second-generation anti-VEGF therapies to support evidence-based management of treatment naïve and previously treated patients with retinal diseases.

    To claim CME credit, please visit HealioCME.com and search for this activity title

    14 min